Pinnacle Associates LTD Amarin Corp Plcuk Transaction History

Pinnacle Associates LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$1.13 - $3.69 $22,656 - $73,984	-20,050 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$3.24 - $5.18 $6,480 - $10,360	2,000 Added 11.08%	20,050 $68,000
Q3 2021 Oct 19, 2021	SELL	$3.94 - $5.84 $11,820 - $17,520	-3,000 Reduced 14.25%	18,050 $92,000
Q2 2021 Aug 02, 2021	BUY	$4.26 - $6.5 $4,260 - $6,500	1,000 Added 4.99%	21,050 $92,000
Q1 2021 May 12, 2021	BUY	$5.03 - $8.8 $100,851 - $176,440	20,050 New	20,050 $125,000
Q1 2020 May 13, 2020	SELL	$4.0 - $21.53 $123,968 - $667,257	-30,992 Closed	0 $0
Q4 2019 Feb 03, 2020	SELL	$13.94 - $24.12 $121,626 - $210,447	-8,725 Reduced 21.97%	30,992 $664,000
Q3 2019 Nov 08, 2019	BUY	$13.89 - $23.16 $38,544 - $64,269	2,775 Added 7.51%	39,717 $602,000
Q2 2019 Aug 05, 2019	BUY	$16.27 - $20.51 $102,126 - $128,741	6,277 Added 20.47%	36,942 $716,000
Q1 2019 May 10, 2019	BUY	$12.61 - $22.33 $137,449 - $243,396	10,900 Added 55.15%	30,665 $637,000
Q4 2018 Feb 05, 2019	SELL	$12.41 - $22.98 $3,847 - $7,123	-310 Reduced 1.54%	19,765 $269,000
Q3 2018 Nov 13, 2018	BUY	$2.45 - $16.27 $49,183 - $326,620	20,075 New	20,075 $327,000

184

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $246M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Associates LTD with notifications on news.